Related references
Note: Only part of the references are listed.Axl and Mertk Receptors Cooperate to Promote Breast Cancer Progression by Combined Oncogenic Signaling and Evasion of Host Antitumor Immunity
Viralkumar Davra et al.
CANCER RESEARCH (2021)
Targeting AXL kinase sensitizes leukemic stem and progenitor cells to venetoclax treatment in acute myeloid leukemia
Xiaojia Niu et al.
BLOOD (2021)
Targeting Axl favors an antitumorigenic microenvironment that enhances immunotherapy responses by decreasing Hif-1α levels
Marie-Anne Goyette et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Normal vitreous promotes angiogenesis via activation of Axl
Wenyi Wu et al.
FASEB JOURNAL (2021)
Engineered IL-7 Receptor Enhances the Therapeutic Effect of AXL-CAR-T Cells on Triple-Negative Breast Cancer
Zhenhui Zhao et al.
BIOMED RESEARCH INTERNATIONAL (2020)
A conserved dendritic-cell regulatory program limits antitumour immunity
Barbara Maier et al.
NATURE (2020)
Guidelines and definitions for research on epithelial-mesenchymal transition
Jing Yang et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)
Gas6 expression is reduced in advanced breast cancers
Ayman M. Ibrahim et al.
NPJ PRECISION ONCOLOGY (2020)
Pericyte FAK negatively regulates Gas6/Axl signalling to suppress tumour angiogenesis and tumour growth
Tanguy Lechertier et al.
NATURE COMMUNICATIONS (2020)
AXL confers cell migration and invasion by hijacking a PEAK1-regulated focal adhesion protein network
Afnan Abu-Thuraia et al.
NATURE COMMUNICATIONS (2020)
A Functional Role of GAS6/TAM in Nonalcoholic Steatohepatitis Progression Implicates AXL as Therapeutic Target
Anna Tutusaus et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2020)
Pan-TAM Tyrosine Kinase Inhibitor BMS-777607 Enhances Anti-PD-1 mAb Efficacy in a Murine Model of Triple-Negative Breast Cancer
Canan Kasikara et al.
CANCER RESEARCH (2019)
Cross-Talk between Receptor Tyrosine Kinases AXL and ERBB3 Regulates Invadopodia Formation in Melanoma Cells
Or-Yam Revach et al.
CANCER RESEARCH (2019)
A niche-dependent myeloid transcriptome signature defines dormant myeloma cells
Weng Hua Khoo et al.
BLOOD (2019)
TAM Kinases Promote Necroptosis by Regulating Oligomerization of MLKL
Ayaz Najafov et al.
MOLECULAR CELL (2019)
Axl signaling is an important mediator of tumor angiogenesis
Mai Tanaka et al.
Oncotarget (2019)
TAM Family Receptor Kinase Inhibition Reverses MDSC-Mediated Suppression and Augments Anti-PD-1 Therapy in Melanoma
Alisha Holtzhausen et al.
CANCER IMMUNOLOGY RESEARCH (2019)
S100A10 Is a Critical Mediator of GAS6/AXL-Induced Angiogenesis in Renal Cell Carcinoma
Yiren Xiao et al.
CANCER RESEARCH (2019)
AXL receptor tyrosine kinase as a promising anti-cancer approach: functions, molecular mechanisms and clinical applications
Chenjing Zhu et al.
MOLECULAR CANCER (2019)
Liquid biopsy-based single-cell metabolic phenotyping of lung cancer patients for informative diagnostics
Ziming Li et al.
NATURE COMMUNICATIONS (2019)
AXL confers intrinsic resistance to osimertinib and advances the emergence of tolerant cells
Hirokazu Taniguchi et al.
NATURE COMMUNICATIONS (2019)
A novel AXL chimeric antigen receptor endows T cells with anti-tumor effects against triple negative breast cancers
Jing Wei et al.
CELLULAR IMMUNOLOGY (2018)
Axl inhibitors as novel cancer therapeutic agents
Yingying Shen et al.
LIFE SCIENCES (2018)
The prognostic role of Gas6/Axl axis in solid malignancies: a meta-analysis and literature review
Sheng Zhang et al.
ONCOTARGETS AND THERAPY (2018)
The Receptor Tyrosine Kinase AXL Is Required at Multiple Steps of the Metastatic Cascade during HER2-Positive Breast Cancer Progression
Marie-Anne Goyette et al.
CELL REPORTS (2018)
Cisplatin and Pemetrexed Activate AXL and AXL Inhibitor BGB324 Enhances Mesothelioma Cell Death from Chemotherapy
Derek B. Oien et al.
FRONTIERS IN PHARMACOLOGY (2018)
Small-Molecule Inhibition of Axl Targets Tumor Immune Suppression and Enhances Chemotherapy in Pancreatic Cancer
Kathleen F. Ludwig et al.
CANCER RESEARCH (2018)
Therapeutic Activity of Anti-AXL Antibody against Triple-Negative Breast Cancer Patient-Derived Xenografts and Metastasis
Wilhem Leconet et al.
CLINICAL CANCER RESEARCH (2017)
Gas6-Axl signaling in presence of Sunitinib is enhanced, diversified and sustained in renal tumor cells, resulting in tumor-progressive advantages
Anna Gustafsson et al.
EXPERIMENTAL CELL RESEARCH (2017)
AXL-GAS6 expression can predict for adverse prognosis in non-small cell lung cancer with brain metastases
Xiaoliang Wu et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2017)
Growth Arrest-Specific 6 Enhances the Suppressive Function of CD4+ CD25+ Regulatory T Cells Mainly through Axl Receptor
Guang-ju Zhao et al.
MEDIATORS OF INFLAMMATION (2017)
Phosphatidylserine Sensing by TAM Receptors Regulates AKT-Dependent Chemoresistance and PD-L1 Expression
Canan Kasikara et al.
MOLECULAR CANCER RESEARCH (2017)
The receptor tyrosine kinase AXL mediates nuclear translocation of the epidermal growth factor receptor
Toni M. Brand et al.
SCIENCE SIGNALING (2017)
The non-invasive serum biomarker soluble Axl accurately detects advanced liver fibrosis and cirrhosis
Katharina Staufer et al.
CELL DEATH & DISEASE (2017)
Axl inhibition induces the antitumor immune response which can be further potentiated by PD-1 blockade in the mouse cancer models
Zhiqiang Guo et al.
ONCOTARGET (2017)
Targeting AXL overcomes resistance to docetaxel therapy in advanced prostate cancer
Jian-Zhong Lin et al.
ONCOTARGET (2017)
The receptor tyrosine kinase AXL mediates nuclear translocation of the epidermal growth factor receptor
Toni M. Brand et al.
SCIENCE SIGNALING (2017)
Integrative Analysis Identifies a Novel AXL-PI3 Kinase-PD-L1 Signaling Axis Associated with Radiation Resistance in Head and Neck Cancer
Heath D. Skinner et al.
CLINICAL CANCER RESEARCH (2017)
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Padmanee Sharma et al.
CELL (2017)
A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal Transition
Milena P. Mak et al.
CLINICAL CANCER RESEARCH (2016)
AXL Inhibitors in Cancer: A Medicinal Chemistry Perspective
Samuel H. Myers et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
ALK inhibitor resistance in ALKF1174L-driven neuroblastoma is associated with AXL activation and induction of EMT
D. N. Debruyne et al.
ONCOGENE (2016)
Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma
L. Zhou et al.
ONCOGENE (2016)
Mechanosensing Controlled Directly by Tyrosine Kinases
Bo Yang et al.
NANO LETTERS (2016)
New twists in the AXL(e) of tumor progression
Balazs Halmos et al.
SCIENCE SIGNALING (2016)
Reprogramming the immunological microenvironment through radiation and targeting Axl
Todd A. Aguilera et al.
NATURE COMMUNICATIONS (2016)
AXL receptor tyrosine kinase is required for T cell priming and antiviral immunity
Edward T. Schmid et al.
ELIFE (2016)
New twists in the AXL(e) of tumor progression
Balazs Halmos et al.
SCIENCE SIGNALING (2016)
Axl-EGFR receptor tyrosine kinase hetero-interaction provides EGFR with access to pro-invasive signalling in cancer cells
M. Vouri et al.
ONCOGENESIS (2016)
Epithelial-Mesenchymal Transition and Breast Cancer
Yanyuan Wu et al.
JOURNAL OF CLINICAL MEDICINE (2016)
Axl is required for TGF-β2-induced dormancy of prostate cancer cells in the bone marrow
Kenji Yumoto et al.
SCIENTIFIC REPORTS (2016)
AXL-associated tumor inflammation as a poor prognostic signature in chemotherapy-treated triple-negative breast cancer patients
Giulia Bottai et al.
NPJ BREAST CANCER (2016)
Hypoxia-Inducible Factors: Master Regulators of Cancer Progression
Luana Schito et al.
TRENDS IN CANCER (2016)
Inhibition of Mer and Axl receptor tyrosine kinases leads to increased apoptosis and improved chemosensitivity in human neuroblastoma
Yixin Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Axl receptor tyrosine kinase is a potential therapeutic target in renal cell carcinoma
H. Yu et al.
BRITISH JOURNAL OF CANCER (2015)
AXL Mediates Resistance to PI3Kα Inhibition by Activating the EGFR/PKC/mTOR Axis in Head and Neck and Esophageal Squamous Cell Carcinomas
Moshe Elkabets et al.
CANCER CELL (2015)
Warfarin Blocks Gas6-Mediated Axl Activation Required for Pancreatic Cancer Epithelial Plasticity and Metastasis
Amanda Kirane et al.
CANCER RESEARCH (2015)
TGF-β Promotes Heterogeneity and Drug Resistance in Squamous Cell Carcinoma
Naoki Oshimori et al.
CELL (2015)
Gas6/Axl pathway is activated in chronic liver disease and its targeting reduces fibrosis via hepatic stellate cell inactivation
Cristina Barcena et al.
JOURNAL OF HEPATOLOGY (2015)
Receptor tyrosine kinase Axl is required for resistance of leukemic cells to FLT3-targeted therapy in acute myeloid leukemia
I-K Park et al.
LEUKEMIA (2015)
Polarization of tumor-associated macrophages and Gas6/Axl signaling in oral squamous cell carcinoma
Kuo-Chou Chiu et al.
ORAL ONCOLOGY (2015)
Novel Axl-driven signaling pathway and molecular signature characterize high-grade ovarian cancer patients with poor clinical outcome
Katia Rea et al.
ONCOTARGET (2015)
Mesenchymal Cancer Cell-Stroma Crosstalk Promotes Niche Activation, Epithelial Reversion, and Metastatic Colonization
Yaiza del Pozo Martin et al.
CELL REPORTS (2015)
The AXL Receptor Is a Sensor of Ligand Spatial Heterogeneity
Aaron S. Meyer et al.
CELL SYSTEMS (2015)
Axl Phosphorylates Elmo Scaffold Proteins To Promote Rac Activation and Cell Invasion
Afnan Abu-Thuraia et al.
MOLECULAR AND CELLULAR BIOLOGY (2015)
AXL Inhibition Sensitizes Mesenchymal Cancer Cells to Antimitotic Drugs
Catherine Wilson et al.
CANCER RESEARCH (2014)
Gas6/Axl pathway promotes tumor invasion through the transcriptional activation of Slug in hepatocellular carcinoma
Hsin-Jung Lee et al.
CARCINOGENESIS (2014)
AXL Is a Key Regulator of Inherent and Chemotherapy-Induced Invasion and Predicts a Poor Clinical Outcome in Early-Stage Colon Cancer
Philip D. Dunne et al.
CLINICAL CANCER RESEARCH (2014)
Receptor Tyrosine Kinases, TYRO3, AXL, and MER, Demonstrate Distinct Patterns and Complex Regulation of Ligand-induced Activation
Wen-I Tsou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Axl receptor tyrosine kinase expression in breast cancer
Timothy M. D'Alfonso et al.
JOURNAL OF CLINICAL PATHOLOGY (2014)
The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells
Magdalena Paolino et al.
NATURE (2014)
An engineered Axl 'decoy receptor' effectively silences the Gas6-Axl signaling axis
Mihalis S. Kariolis et al.
NATURE CHEMICAL BIOLOGY (2014)
AXL induces epithelial-to-mesenchymal transition and regulates the function of breast cancer stem cells
M. K. Asiedu et al.
ONCOGENE (2014)
Direct regulation of GAS6/AXL signaling by HIF promotes renal metastasis through SRC and MET
Erinn B. Rankin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
The TAM family: phosphatidylserine-sensing receptor tyrosine kinases gone awry in cancer
Douglas K. Graham et al.
NATURE REVIEWS CANCER (2014)
Mechanisms of disseminated cancer cell dormancy: an awakening field
Maria Soledad Sosa et al.
NATURE REVIEWS CANCER (2014)
T Cell-Derived Protein S Engages TAM Receptor Signaling in Dendritic Cells to Control the Magnitude of the Immune Response
Eugenio A. Carrera Silva et al.
IMMUNITY (2013)
AXL and MET crosstalk to promote gonadotropin releasing hormone (GnRH) neuronal cell migration and survival
Smita Salian-Mehta et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2013)
Axl Mediates Acquired Resistance of Head and Neck Cancer Cells to the Epidermal Growth Factor Receptor Inhibitor Erlotinib
Keith M. Giles et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Mer or Axl receptor tyrosine kinase inhibition promotes apoptosis, blocks growth and enhances chemosensitivity of human non-small cell lung cancer
R. M. A. Linger et al.
ONCOGENE (2013)
The Receptor AXL Diversifies EGFR Signaling and Limits the Response to EGFR-Targeted Inhibitors in Triple-Negative Breast Cancer Cells
Aaron S. Meyer et al.
SCIENCE SIGNALING (2013)
Biology of the TAM Receptors
Greg Lemke
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)
Axl is essential for VEGF-A-dependent activation of PI3K/Akt
Guo-Xiang Ruan et al.
EMBO JOURNAL (2012)
Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer
Zhenfeng Zhang et al.
NATURE GENETICS (2012)
Cross-Phosphorylation, Signaling and Proliferative Functions of the Tyro3 and Axl Receptors in Rat2 Cells
Jessica E. Brown et al.
PLOS ONE (2012)
Direct Signaling between Platelets and Cancer Cells Induces an Epithelial-Mesenchymal-Like Transition and Promotes Metastasis
Myriam Labelle et al.
CANCER CELL (2011)
CURRENT CONCEPTS Hepatocellular Carcinoma
Hashem B. El-Serag
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer
K. Vuoriluoto et al.
ONCOGENE (2011)
AXL Is an Essential Factor and Therapeutic Target for Metastatic Ovarian Cancer
Erinn B. Rankin et al.
CANCER RESEARCH (2010)
R428, a Selective Small Molecule Inhibitor of Axl Kinase, Blocks Tumor Spread and Prolongs Survival in Models of Metastatic Breast Cancer
Sacha J. Holland et al.
CANCER RESEARCH (2010)
An anti-Axl monoclonal antibody attenuates xenograft tumor growth and enhances the effect of multiple anticancer therapies
X. Ye et al.
ONCOGENE (2010)
Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival
Christine Gjerdrum et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
GAS6/AXL Axis Regulates Prostate Cancer Invasion, Proliferation, and Survival in the Bone Marrow Niche
Yusuke Shiozawa et al.
NEOPLASIA (2010)
Novel Mechanism of Lapatinib Resistance in HER2-Positive Breast Tumor Cells: Activation of AXL
Li Liu et al.
CANCER RESEARCH (2009)
Localized and reversible TGFβ signalling switches breast cancer cells from cohesive to single cell motility
Silvia Giampieri et al.
NATURE CELL BIOLOGY (2009)
Axl as a potential therapeutic target in cancer: role of Axl in tumor growth, metastasis and angiogenesis
Y. Li et al.
ONCOGENE (2009)
Growth arrest-specific gene 6 expression in human breast cancer
O. Mc Cormack et al.
BRITISH JOURNAL OF CANCER (2008)
Vaccinia virus uses macropinocytosis and apoptotic mimicry to enter host cells
Jason Mercer et al.
SCIENCE (2008)
TAM receptors are pleiotropic inhibitors of the innate immune response
Carla V. Rothlin et al.
CELL (2007)
A novel tyrosine kinase switch is a mechanism of imatinib resistance in gastrointestinal stromal tumors
D. Mahadevan et al.
ONCOGENE (2007)
Macrophages and dendritic cells use different Axl/Mertk/Tyro3 receptors in clearance of apoptotic cells
Heather M. Seitz et al.
JOURNAL OF IMMUNOLOGY (2007)
Signalling and functional diversity within the Axl subfamily of receptor tyrosine kinases
Sassan Hafizi et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2006)
Expression of Axl in lung adenocarcinoma and correlation with tumor progression
YS Shieh et al.
NEOPLASIA (2005)
Multiple roles for the receptor tyrosine kinase Axl in tumor formation
SJ Holland et al.
CANCER RESEARCH (2005)
Hydrogen peroxide activates the Gas6-Axl pathway in vascular smooth muscle cells
A Konishi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Mer receptor tyrosine kinase signaling participates in platelet function
CL Chen et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
An RCS-like retinal dystrophy phenotype in Mer knockout mice
JL Duncan et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2003)
Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family
QX Lu et al.
SCIENCE (2001)
Phagocytosis and clearance of apoptotic cells is mediated by MER
RS Scott et al.
NATURE (2001)
Share Paper
